These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23369681)

  • 1. International rare cancers initiative.
    Keat N; Law K; Seymour M; Welch J; Trimble T; Lascombe D; Negrouk A
    Lancet Oncol; 2013 Feb; 14(2):109-10. PubMed ID: 23369681
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.
    Bogaerts J; Sydes MR; Keat N; McConnell A; Benson A; Ho A; Roth A; Fortpied C; Eng C; Peckitt C; Coens C; Pettaway C; Arnold D; Hall E; Marshall E; Sclafani F; Hatcher H; Earl H; Ray-Coquard I; Paul J; Blay JY; Whelan J; Panageas K; Wheatley K; Harrington K; Licitra L; Billingham L; Hensley M; McCabe M; Patel PM; Carvajal R; Wilson R; Glynne-Jones R; McWilliams R; Leyvraz S; Rao S; Nicholson S; Filiaci V; Negrouk A; Lacombe D; Dupont E; Pauporté I; Welch JJ; Law K; Trimble T; Seymour M
    Eur J Cancer; 2015 Feb; 51(3):271-81. PubMed ID: 25542058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial design for rare cancers: why a less conventional route may be required.
    Panageas KS
    Expert Rev Clin Pharmacol; 2015; 8(6):661-3. PubMed ID: 26517109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Children's Oncology Group's 2013 blueprint for research: rare tumors.
    Rodriguez-Galindo C; Krailo M; Frazier L; Chintagumpala M; Amatruda J; Katzenstein H; Malogolowkin M; Spector L; Pashankar F; Meyers R; Tomlinson G;
    Pediatr Blood Cancer; 2013 Jun; 60(6):1016-21. PubMed ID: 23255219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. development of a therapeutic approach to rare cancers in children: the Children's Oncology Group experience.
    Pashankar FD; Rodriguez-Galindo C; Pappo A
    J Pediatr Hematol Oncol; 2012 May; 34 Suppl 2():S37-8. PubMed ID: 22525404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare cancers in children - The EXPeRT Initiative: a report from the European Cooperative Study Group on Pediatric Rare Tumors.
    Bisogno G; Ferrari A; Bien E; Brecht IB; Brennan B; Cecchetto G; Godzinski J; Orbach D; Reguerre Y; Stachowicz-Stencel T; Schneider DT
    Klin Padiatr; 2012 Oct; 224(6):416-20. PubMed ID: 23143769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenge of very rare tumours in childhood: the Italian TREP project.
    Ferrari A; Bisogno G; De Salvo GL; Indolfi P; Perilongo G; Cecchetto G; ;
    Eur J Cancer; 2007 Mar; 43(4):654-9. PubMed ID: 17049226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The founding of the European Cooperative Study Group on Pediatric Rare Tumors--EXPeRT.
    Ferrari A; Schneider DT; Bisogno G;
    Expert Rev Anticancer Ther; 2013 Jan; 13(1):1-3. PubMed ID: 23259419
    [No Abstract]   [Full Text] [Related]  

  • 9. Progress in Rare Diseases Research 2010-2016: An IRDiRC Perspective.
    Dawkins HJS; Draghia-Akli R; Lasko P; Lau LPL; Jonker AH; Cutillo CM; Rath A; Boycott KM; Baynam G; Lochmüller H; Kaufmann P; Le Cam Y; Hivert V; Austin CP;
    Clin Transl Sci; 2018 Jan; 11(1):11-20. PubMed ID: 28796411
    [No Abstract]   [Full Text] [Related]  

  • 10. A unifying strategy for clinical trials in rare urological malignancy.
    Nicholson S
    Nat Clin Pract Urol; 2008 Dec; 5(12):652-3. PubMed ID: 19015645
    [No Abstract]   [Full Text] [Related]  

  • 11. Pediatric pancreatic tumors: the orphan looking for a home.
    Brennan B
    Pediatr Blood Cancer; 2010 May; 54(5):659-60. PubMed ID: 20063425
    [No Abstract]   [Full Text] [Related]  

  • 12. Should clinical trials be approached differently for rare cancers?
    Olver I
    Future Oncol; 2016 May; 12(10):1207-9. PubMed ID: 26939845
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rare tumours: a new heading in Bulletin du cancer].
    Massard C; Droz JP
    Bull Cancer; 2010 Sep; 97(9):1031-9. PubMed ID: 20813656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rare pulmonary diseases: from the adoption of orphan diseases to structured healthcare networks].
    Cottin V; Cordier JF
    Rev Mal Respir; 2014 Dec; 31(10):889-92. PubMed ID: 25465349
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategy for randomised clinical trials in rare cancers.
    Tan SB; Dear KB; Bruzzi P; Machin D
    BMJ; 2003 Jul; 327(7405):47-9. PubMed ID: 12842959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.
    Ray-Coquard I; Trama A; Seckl MJ; Fotopoulou C; Pautier P; Pignata S; Kristensen G; Mangili G; Falconer H; Massuger L; Sehouli J; Pujade-Lauraine E; Lorusso D; Amant F; Rokkones E; Vergote I; Ledermann JA;
    Eur J Surg Oncol; 2019 Jan; 45(1):67-74. PubMed ID: 29108961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do we need randomised trials for rare cancers?
    Prasad V; Oseran A
    Eur J Cancer; 2015 Jul; 51(11):1355-7. PubMed ID: 25963018
    [No Abstract]   [Full Text] [Related]  

  • 18. [Methodology and management of clinical trials with small number of patients for rare diseases].
    Micallef J
    Presse Med; 2012 May; 41 Suppl 1():S32-4. PubMed ID: 22483773
    [No Abstract]   [Full Text] [Related]  

  • 19. Rare Tumors in Children: Progress Through Collaboration.
    Pappo AS; Furman WL; Schultz KA; Ferrari A; Helman L; Krailo MD
    J Clin Oncol; 2015 Sep; 33(27):3047-54. PubMed ID: 26304909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving treatment results with reference centres for rare cancers: where do we stand?
    Ray-Coquard I; Pujade Lauraine E; Le Cesne A; Pautier P; Vacher Lavenue MC; Trama A; Casali P; Coindre JM; Blay JY
    Eur J Cancer; 2017 May; 77():90-98. PubMed ID: 28384534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.